FDA Inspection
VitalantVitalant – FDA Inspection, Mar 2, 2026
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on March 2, 2026, issued by the Denver District Office, covering biologics.
View Company Profile
ID · f7653b44-05a2-40bb-8156-9bd029eeb127
Inspection Facts
- Inspection number
- 1305116
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.40(a)(1)Provide space for examination
- 21 CFR 640.4(e)Donor identification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 3, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1194288 - 2022-12-07
- FDA Inspection 1075127 - 2018-10-23
- FDA Inspection 998084 - 2016-12-08
- FDA Inspection 913511 - 2015-02-10
- FDA Inspection 857599 - 2013-12-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.